Â鶹ӰԺ

The state is heading in the right direction, but still has a lot of work to do before it can remove all public health restrictions, such as mask mandates, researchers say.

A new study of mask compliance across 53 campuses, including CU Â鶹ӰԺ, suggests that while there's some room for improvement, college students are listening to public health advice and wearing face coverings.

Venture Partners at CU Â鶹ӰԺ has launched an accelerator to support the translation of CU-developed COVID-19 innovations into new businesses. Faculty, students and staff with COVID-19-related innovations are invited to apply—the deadline is May 21.

The current COVID-19 pandemic and other disease outbreaks aren't just biological phenomena, a team of archaeologists argue—these events are also shaped by the broader welfare of human societies.

Meet PortaVax, a portable vaccine carrier that can keep up to 250 vaccine doses cold for several days using insulation and dry ice. Students are still testing the device and tweaking its design, but they say early results are promising.

A dedicated team of faculty, staff and students has been working around the clock since the start of the fall semester to monitor the virus that causes COVID-19 in our campus wastewater. It's been critical to keeping campus safe during this pandemic, and systems like it could even help us catch the next one.

Hear about Lori Peek's formative years in small-town Kansas, her love for teaching and mentoring and how her research is helping us learn from disasters like Hurricane Katrina and the COVID-19 pandemic. Peek is a professor, faculty associate at the Institute of Behavioral Science and the director of the Natural Hazards Center.

CU Â鶹ӰԺ was the first site to roll out a federally-funded study led by the COVID-19 Prevention Network at the Fred Hutchinson Cancer Research Center in Seattle. Study leaders vaccinated 11 of the roughly 700 CU Â鶹ӰԺ student volunteers who will ultimately participate.

Distinguished Professor Tom Cech will present a virtual lecture titled “The Magic of RNA: From CRISPR to Coronavirus Vaccines," focusing on how RNA has become better understood and how those discoveries have unlocked exciting new medical possibilities.

As supply increases, so do questions about how the COVID-19 vaccines work and what they do and don’t do. We caught up with Professor Matt McQueen, director of epidemiology, for answers.